Paper42479110
Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance.
Paul BM and 3 others. Inflammopharmacology, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance. Papers, record 42479110. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42479110
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ovarian Neoplasms | Major topic |
| Cytokines | Major topic |
| Inflammation | Major topic |
| Biological Products | Major topic |
| Senescence-Associated Secretory Phenotype | Major topic |
| Humans | |
| Female | |
| Animals | |
| Cellular Senescence | |
| Drug Resistance, Neoplasm | |
| Tumor Microenvironment | |
| Epithelial-Mesenchymal Transition | |
| Tumor Escape |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PHD-MEDHA-2023-10970 | Bayer Foundation | PubMed | ||
| CMRG/3005/H3/2024/011 | Directorate of Technical Education - Chief Minister Research Grant | PubMed | ||
| EEQ/2021/000203 | Science and Engineering Research Board | PubMed |
Source PubMed
References278
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27919958 | Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells. | Anticancer Res | 2016 | https://conductscience.org/library/papers/27919958 | PubMed |
| 2 | 37814270 | Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37814270 | PubMed |
| 3 | 29173024 | Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9. | Cancer Biol Ther | 2017 | https://conductscience.org/library/papers/29173024 | PubMed |
| 4 | 24384374 | Liposomal siRNA nanocarriers for cancer therapy. | Adv Drug Deliv Rev | 2014 | https://conductscience.org/library/papers/24384374 | PubMed |
| 5 | 38267628 | The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. | Nat Cancer | 2024 | https://conductscience.org/library/papers/38267628 | PubMed |
| 6 | 37441528 | Antiaging effects of dietary supplements and natural products. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37441528 | PubMed |
| 7 | 33968932 | The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/33968932 | PubMed |
| 8 | 34645978 | A highly annotated database of genes associated with platinum resistance in cancer. | Oncogene | 2021 | https://conductscience.org/library/papers/34645978 | PubMed |
| 9 | 40872567 | Network Pharmacology and Machine Learning Identify Flavonoids as Potential Senotherapeutics. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872567 | PubMed |
| 10 | 30988303 | Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells. | Exp Mol Med | 2019 | https://conductscience.org/library/papers/30988303 | PubMed |
| 11 | 22313874 | Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. | Semin Cancer Biol | 2012 | https://conductscience.org/library/papers/22313874 | PubMed |
| 12 | 36098323 | The costs and benefits of senotherapeutics for human health. | Lancet Healthy Longev | 2022 | https://conductscience.org/library/papers/36098323 | PubMed |
| 13 | 38940746 | A second generation of senotherapies: the development of targeted senolytics, senoblockers and senoreversers for healthy ageing. | Biochem Soc Trans | 2024 | https://conductscience.org/library/papers/38940746 | PubMed |
| 14 | 38604701 | Chemical Strategies for the Detection and Elimination of Senescent Cells. | Acc Chem Res | 2024 | https://conductscience.org/library/papers/38604701 | PubMed |
| 15 | 38321020 | Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment. | NPJ Aging | 2024 | https://conductscience.org/library/papers/38321020 | PubMed |
| 16 | 41513104 | Chlorogenic acid attenuates endometrial senescence via mTOR modulation: A combined network pharmacology, in vitro, and in vivo study. | Biochem Pharmacol | 2026 | https://conductscience.org/library/papers/41513104 | PubMed |
| 17 | 31113465 | Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31113465 | PubMed |
| 18 | 32555170 | Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32555170 | PubMed |
| 19 | 32849491 | Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. | Front Immunol | 2020 | https://conductscience.org/library/papers/32849491 | PubMed |
| 20 | 37301862 | Discovery of senolytics using machine learning. | Nat Commun | 2023 | https://conductscience.org/library/papers/37301862 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ASPRV1 | 151516 | PubTator's text mining | https://conductscience.org/library/genes/151516 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42479110
GET https://conductscience.org/api/papers/v1/42479110/references?page=2